About 2,445 results

ALLMedicine™ Apraxia Center

Research & Reviews  878 results

A Neurosurgical Functional Dissection of the Middle Precentral Gyrus during Speech Prod...
The Journal of Neuroscience : the Official Journal of The... Silva AB, Liu JR et. al.

Nov 10th, 2022 - Classical models have traditionally focused on the left posterior inferior frontal gyrus (Broca's area) as a key region for motor planning of speech production. However, converging evidence suggests that it is not critical for either speech motor ...

In-depth characterisation of a cohort of individuals with missense and loss-of-function...
Journal of Medical Genetics; Morison LD, Meffert E et. al.

Nov 4th, 2022 - Heterozygous disruptions of FOXP2 were the first identified molecular cause for severe speech disorder: childhood apraxia of speech (CAS), and yet few cases have been reported, limiting knowledge of the condition. Here we phenotyped 28 individuals...

Changing perspectives on frontotemporal dementia: A review.
Journal of Neuropsychology; Snowden JS

Nov 1st, 2022 - This article examines the evolution in understanding of frontotemporal dementia (FTD) during the last four decades. A central theme is the recognition of heterogeneity. Originally construed as a disorder of behaviour and executive impairment, FTD ...

Acoustic and Kinematic Assessment of Motor Speech Impairment in Patients With Suspected...
Journal of Speech, Language, and Hearing Research : JSLHR; Cordella C, Gutz SE et. al.

Oct 29th, 2022 - The aim of this study was to use acoustic and kinematic speech measures to characterize type of motor speech impairment-apraxia of speech (AOS) versus dysarthria-in individuals with four-repeat tauopathy (4RT)-associated syndromes, including nonfl...

Delayed encephalopathy after COVID-19: A case series of six patients.
Medicine Akimoto T, Hara M et. al.

Oct 26th, 2022 - Acute encephalopathy is a severe neurological complication of coronavirus disease 2019 (COVID-19). Most cases of acute encephalopathy associated with COVID-19 occur within several weeks of COVID-19 onset. We describe a case series of 6 patients wh...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  65 results

Validation Study of SCALA, Scale for Lateropulsion

Sep 21st, 2022 - The protocol aims to develop and validate a new clinical rating scale assessing lateropulsion after stroke. The project is driven by the need to have a tool that better meets clinometric properties than the 2 main existing scales, the Scale for Co...

Treating Childhood Apraxia of Speech

Sep 21st, 2022 - Childhood apraxia of speech is a developmental speech sound disorder that may lead to persisting speech errors, often despite years of treatment. Such impairments may lead to social, academic, and vocational limitations. Thus, there is a need to e...

Expanded Access Protocol: Umbilical Cord Blood Infusions for Children With Brain Injuries

Sep 9th, 2022 - The primary purpose of this protocol is to enable access to sibling or autologous umbilical cord blood for children with various brain disorders. Children with autism, apraxia, cerebral palsy, hydrocephalus, hypoxic brain injury, stroke, and other...

MIRAA - Implementation of Intensive Rehabilitation of Aphasia and/or Apraxia of Speech in Swedish Healthcare

Sep 2nd, 2022 - According to the Swedish National Board of Health and Welfare's guidelines for stroke care, persons with aphasia shall be offered intensive rehabilitation by speech-language pathologists. The aphasia rehabilitation is however sparse and unevenly d...

The Effects of Telerehabilitation-Based Spinal Stabilization Exercises in Stroke Patients

Aug 17th, 2022 - Stroke is defined as a neurological disorder that causes acute focal damage to the Central Nervous System due to a vascular cause. Ischemic stroke and hemorrhagic stroke are the two most fundamental types of stroke. Approximately 80% of patients s...

see more →

News  15 results

Biomarker Hunt Focuses on Predicting Immunotherapy Adverse Events

Dec 5th, 2020 - Douglas B. Johnson, MD Findings from recent studies have begun to answer a question that oncologists have been asking since the FDA approved the first immune checkpoint inhibitor, ipilimumab (Yervoy), in 2011: Which patients will tolerate a parti...

Inhaled Heroin Tied to 'Peculiar, Often Catastrophic' Brain Damage

Jul 9th, 2018 - "Chasing the dragon" (CTD) — a method of inhaling heroin in which users heat heroin over aluminium foil with a lighter and then chase the fumes — is growing in popularity and may lead to "peculiar and often catastrophic brain complications," new r...

Can Botulinum Toxin Benefit People With Parkinson’s Disease?

Apr 25th, 2017 - Robert Chen, MBBChir MIAMI—Botulinum toxin may be a clinically useful treatment for motor and nonmotor manifestations of Parkinson’s disease and parkinsonism, according to an overview presented at the First Pan American Parkinson’s Disease and Mov.

Alemtuzumab Linked to CNS Inflammation

Jan 26th, 2017 - Two cases of what is suggested to be "the first recognised cases of severely exacerbated CNS [central nervous system] inflammation after alemtuzumab therapy in multiple sclerosis" have been published. Writing in a letter in the February issue of T...

Experts review challenges, pearls in young onset dementia
Amy Karon

Sep 19th, 2016 - SAN FRANCISCO – The patient, a man in his early 50s, smiled as he sang about flatulence. He seemed alert, relaxed, and aware of his wife and the neurologist in the room.

see more →

Patient Education  19 results see all →